Our clients are changing the world. We make sure the world knows it. That has been our agency slogan for more than a quarter-century, highlighting our commitment to storytelling. So, when our client Brad Loncar asked us to help him develop powerful educational content that would articulate the investment case for the China biopharma industry, we jumped at the chance to go behind the scenes of a fast-growing sector within one of the most rapidly evolving economies in the world.
Brad and his firm, Loncar Investments, debuted their second ETF product, the Loncar China BioPharma ETF (CHNA), on the Nasdaq exchange Aug. 15. Working with Brad and his team, we developed a game plan to interview research scientists, executives and capital-markets participants in Shanghai and Hong Kong to showcase the exciting innovation and growth in the Chinese biopharma business. This week and next, our video team is on the ground in China capturing the story.
Before departing for their exciting expedition, Gregory FCA Vice President Leah Katsanis and Digital Director Karl Leisch took a couple minutes to shoot this insightful preview video. Click below to learn more about the enlightening interviews they’ll conduct with Chinese biopharma leaders during this unforgettable journey to a fascinating foreign land!